Hypertension improvement and when medication needs revisiting posts 61–80
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
I have been on both sides of the hypertension improvement argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.
I have seen it go both ways, which is why I hedge.
Taking post #61 at face value and following it one step further.
Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public.
I would put the burden of proof on the interesting explanation, not the dull one.
Clear enough that I do not think I have a follow-up, which is unusual.
Building on post #65 rather than restating it.
Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.
Careful with the language on hypertension improvement. "Not detected" and "not present" are different findings and the first is a statement about the method.
Adding the measurement that post #69 says would settle it.
Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.
The answer changed when I changed how I was measuring, which was informative.
I changed my mind about hypertension improvement after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it happens.
What would change my mind on hypertension improvement is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.
Building on post #72 rather than restating it.
Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.
A request rather than an answer: could whoever has the primary source for hypertension improvement post it? I have seen the claim three times this month and each version had lost a qualifier.
The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about.
The short answer was in the first line; everything after is the working.
The useful distinction on hypertension improvement is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Where I part company with post #75, and it is a narrow parting.
Speaking only to hypertension improvement as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect.
Adding the measurement that post #76 says would settle it.
Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Hepatic steatosis: what the MASH trial evidence supports — one year on
On the subject in the title: Hepatic steatosis: what the MASH trial evidence supports — one year on Working notes rather than a conclusion. Reading back through what has been written here about Hepatic…
|
2 | 4.1k | 6mo | |
|
Cardiovascular risk: reading the outcome trials as a set
Cardiovascular risk: reading the outcome trials as a set Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here about cardiovascular…
|
4 | 12k | 5mo | |
|
About the Comorbidities category
Type 2 diabetes, hepatic steatosis, sleep apnoea, cardiovascular and renal disease. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 16k | 12h | |
|
Osteoarthritis and mechanical versus metabolic improvement — one year on
On the subject in the title: Osteoarthritis and mechanical versus metabolic improvement — one year on Working notes rather than a conclusion. Collecting what is known about Osteoarthritis and mechanical…
|
+52 | 56 | 8.1k | 15d |
|
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. Working notes on Heart failure with preserved ejection rather…
|
+4 | 8 | 43k | 17mo |
Related topics — sharing the tags type 2 diabetes, MASH / hepatic steatosis, chronic kidney disease
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Preparing for an appointment: one page, three questions
Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. A question about how to describe something to a clinician rather…
|
+28 | 32 | 57k | 11mo |
|
How to ask for a dose change without antagonising anyone
The question in the title: How to ask for a dose change without antagonising anyone I will give what I have already checked below so nobody repeats it. A question about how to describe something to a…
|
+19 | 23 | 2.9k | 23mo |
|
[2026 update] People with a low starting BMI: where the evidence stops
People with a low starting BMI: where the evidence stops Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+19 | 23 | 62k | 23mo |
|
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully
Semaglutide versus liraglutide head to head: reading STEP 8 carefully — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on…
|
+1 | 5 | 11k | 20mo |
|
The most common factual error about semaglutide on the internet
On the subject in the title: The most common factual error about semaglutide on the internet Working notes rather than a conclusion. Putting the numbers in the first post, because a question about a compound…
|
2 | 49k | 2y |